Our top pick for
Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
Enova International Inc is a credit services business based in the US. Enova International shares (ENVA) are listed on the NYSE and all prices are listed in US Dollars. Enova International employs 1,549 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$35.12|
|52-week range||$15.50 - $41.06|
|50-day moving average||$33.89|
|200-day moving average||$34.08|
|Wall St. target price||$43.25|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$13.57|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-15)||-2.58%|
|1 month (2021-09-22)||7.93%|
|3 months (2021-07-22)||11.92%|
|6 months (2021-04-22)||9.41%|
|1 year (2020-10-22)||102.77%|
|2 years (2019-10-22)||67.16%|
|3 years (2018-10-22)||46.64%|
|5 years (2016-10-21)||283.83%|
Valuing Enova International stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Enova International's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Enova International's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 3x. In other words, Enova International shares trade at around 3x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
|Revenue TTM||$837.5 million|
|Operating margin TTM||50.52%|
|Gross profit TTM||$501.2 million|
|Return on assets TTM||24.21%|
|Return on equity TTM||61.23%|
|Market capitalisation||$1.3 billion|
TTM: trailing 12 months
There are currently 1.6 million Enova International shares held short by investors – that's known as Enova International's "short interest". This figure is 1.8% down from 1.6 million last month.
There are a few different ways that this level of interest in shorting Enova International shares can be evaluated.
Enova International's "short interest ratio" (SIR) is the quantity of Enova International shares currently shorted divided by the average quantity of Enova International shares traded daily (recently around 185991.88876014). Enova International's SIR currently stands at 8.63. In other words for every 100,000 Enova International shares traded daily on the market, roughly 8630 shares are currently held short.
However Enova International's short interest can also be evaluated against the total number of Enova International shares, or, against the total number of tradable Enova International shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Enova International's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 Enova International shares in existence, roughly 40 shares are currently held short) or 0.0487% of the tradable shares (for every 100,000 tradable Enova International shares, roughly 49 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Enova International.
Find out more about how you can short Enova International stock.
We're not expecting Enova International to pay a dividend over the next 12 months.
Over the last 12 months, Enova International's shares have ranged in value from as little as $15.5 up to $41.06. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Enova International's is 1.718. This would suggest that Enova International's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Enova International, Inc. , a technology and analytics company, provides online financial services in the United States, Brazil, Australia, and Canada. The company offers installment loans; line of credit accounts; receivables purchase agreements; income share agreements; CSO programs, including arranging loans with independent third-party lenders and assisting in the preparation of loan applications and loan documents; and bank programs, such as marketing services and loan servicing for near-prime unsecured consumer installment loan. It also provides Enova Decisions, an analytics as a service designed to automate or augment customer decisions, which include credit risk, fraud risk, identity verification, customer profitability, payments, and collection. The company markets its financing products under the CashNetUSA, NetCredit, OnDeck, Headway Capital, The Business Backer, and Simplic names. Enova International, Inc. was incorporated in 2011 and is headquartered in Chicago, Illinois.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.